For Lupus Awareness Month, Exagen Calls Attention to Need for Earlier Diagnosis and Treatment

Lupus remains a poorly known or understood disease, with a recent poll by the Lupus Foundation of America finding 51 percent of respondents worldwide did not even know it is a disease — and one that affects an estimated five million people worldwide. Because such lack of awareness can extent…

Exagen Partners with GSK to Raise Awareness of Its Lupus Diagnostic and Monitoring Tests

Exagen Diagnostics is collaborating with GlaxoSmithKline (GSK) to bring greater awareness of its laboratory tests, meant to facilitate early diagnosis and management of systemic lupus erythematosus (SLE). Under the agreement, GSK will provide information to a group of healthcare professionals about Exagen’s AVISE tests. The aim of both companies…